IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
1.080
-0.080 (-6.90%)
Mar 31, 2025, 2:12 PM EDT - Market open
IO Biotech Employees
IO Biotech had 68 employees as of December 31, 2023. The number of employees increased by 11 or 19.30% compared to the previous year.
Employees
68
Change (1Y)
11
Growth (1Y)
19.30%
Revenue / Employee
n/a
Profits / Employee
-$1,328,529
Market Cap
71.15M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 68 | 11 | 19.30% |
Dec 31, 2022 | 57 | 25 | 78.13% |
Dec 31, 2021 | 32 | 21 | 190.91% |
Dec 31, 2020 | 11 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IOBT News
- 5 days ago - IO Biotech Announces Acceptance of Abstracts to be Presented at the 2025 American Association for Cancer Research (AACR) Annual Meeting - GlobeNewsWire
- 13 days ago - IO Biotech Named Among Fast Company's World's Most Innovative Companies of 2025 - GlobeNewsWire
- 26 days ago - IO Biotech Reports 2024 Business Highlights - GlobeNewsWire
- 5 weeks ago - IO Biotech Announces New Preclinical Data for Additional Pipeline Candidate Presented at the AACR-IO Conference - GlobeNewsWire
- 5 weeks ago - IO Biotech to Present at the 45th Annual Cowen Health Care Conference - GlobeNewsWire
- 7 weeks ago - IO Biotech Announces Publication of Preclinical Data Investigating Immune-Modulatory Effects of IO112, an Arginase 1-Targeting Therapeutic Cancer Vaccine Candidate - GlobeNewsWire
- 2 months ago - IO Biotech Completes Enrollment in Phase 2 Trial of its Investigational, Off-the-shelf Therapeutic Cancer Vaccine, IO102-IO103, as Neoadjuvant/Adjuvant Treatment for Patients with Resectable Melanoma or Head and Neck Cancer - GlobeNewsWire
- 3 months ago - IO Biotech secures up to €57.5 million in debt financing from the European Investment Bank - GlobeNewsWire